Literature DB >> 7995993

Peptidoglycan isolated from nontypeable Haemophilus influenzae induces experimental otitis media in the chinchilla.

E R Leake1, K Holmes, D J Lim, T F DeMaria.   

Abstract

Bacterial cell wall components induce a number of biologic effects and promote inflammatory changes in a variety of hosts. Peptidoglycan isolated from Streptococcus pneumoniae can induce inflammation in the middle ear; however, an analogous role for peptidoglycan derived from gram-negative otitis media pathogens has not been described. Peptidoglycan isolated from nontypeable Haemophilus influenzae (NTHi), a major cause of otitis media, was evaluated in a chinchilla model. The direct injection of the middle ear with 3-300 micrograms of peptidoglycan resulted in tympanic membrane inflammation, abnormal pressure in the middle ear, leukocytosis, and histopathologic changes in the middle ear mucosa that included marked edema, osteoneogenesis, focal hemorrhage, and a mononuclear infiltration into the subepithelial space. These data indicate that NTHi peptidoglycan induced inflammation and histopathologic changes in the tympanic membrane and middle ear mucosal epithelium and may contribute to the pathogenesis of otitis media.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995993     DOI: 10.1093/infdis/170.6.1532

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Haemophilus influenzae: then and now.

Authors:  J Z Jordens; M P Slack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

2.  Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media.

Authors:  T F DeMaria; M A Apicella; W A Nichols; E R Leake
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 3.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

4.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces.

Authors:  Adam J Ratner; Elena S Lysenko; Marina N Paul; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  The role of DNA sensing and innate immune receptor TLR9 in otitis media.

Authors:  Anke Leichtle; Michelle Hernandez; Jasmine Lee; Kwang Pak; Nicholas J Webster; Barbara Wollenberg; Stephen I Wasserman; Allen F Ryan
Journal:  Innate Immun       Date:  2011-01-14       Impact factor: 2.680

6.  Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas.

Authors:  X X Gu; J Sun; S Jin; S J Barenkamp; D J Lim; J B Robbins; J Battey
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.

Authors:  T F DeMaria; D M Murwin; E R Leake
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

9.  TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Kenshi Yamasaki; Chun-Fang Cheng; Nicholas J Webster; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2009-07-08       Impact factor: 2.680

10.  The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Nicholas J Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2009-08-05       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.